Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bionano Genomics Inc
(NQ:
BNGO
)
0.3934
-0.0092 (-2.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bionano Genomics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 02, 2021
Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock increased by 16.73% to $14.86 during Tuesday's regular session. The current volume of 1.0 million shares is 269.7%...
Via
Benzinga
Unusual Options Activity Insight: Bionano Genomics
August 06, 2021
Bionano Genomics (NASDAQ:BNGO) shares experienced unusual ...
Via
Benzinga
2 Best Biotech Stocks to Buy in November
November 01, 2021
Bionano Genomics and Ocugen could both be gearing up for a healthy rally this month.
Via
The Motley Fool
Bionano Genomics Is Still Set to Pay Off Big for Patient Investors
October 28, 2021
BNGO stock is no longer a fast money trade. But that's hardly a reason to skip out on it, given its massive potential.
Via
InvestorPlace
Jim Cramer Prefers This Stock Over Mogo, Considers Endeavor Group As Inexpensive
October 19, 2021
On CNBC’s "Mad Money Lightning Ro...
Via
Benzinga
Bionano Genomics’ Latest Software Business Acquisition Adds Immense Value
October 19, 2021
BNGO stock isn't a darling of the markets at the moment, but Bionano continues to advance its stature in the optical genome mapping niche.
Via
InvestorPlace
Bionano Genomics Stock Looks Ready to Reward Patient Investors
October 18, 2021
BNGO stock is down 25% since year to date. But as the company begins to deliver consistent revenue, a prudent investment may be rewarded.
Via
InvestorPlace
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
What's Up With Bionano Genomics Today?
October 12, 2021
Bionano Genomics Inc. (NASDAQ: BNGO) shares are trading higher Tuesday after the company announced it agreed to buy BioDiscovery Inc, a provider of software for analysis,...
Via
Benzinga
BNGO Stock: The Big Acquisition News Sending Bionano Genomics Soaring
October 12, 2021
Bionano has just made a deal that will help it secure a spot among biotech companies riding the wave of the current boom. BNGO stock is up.
Via
InvestorPlace
Exposures
COVID-19
Groundbreaking Tech Makes Bionano Genomics Look Better Than Ever
October 07, 2021
Off and on the price chart, Bionano Genomics could be the next big thing in genomics with multiple catalysts for BNGO stock.
Via
InvestorPlace
BNGO Stock: What Is Driving Bionano Genomics Higher Today?
September 30, 2021
Today, investors in Bionano Genomics and BNGO stock are cheering some positive clinical trial data around optical genome mapping.
Via
InvestorPlace
Bionano Genomics Remains Promising With Global Product Adoption
September 21, 2021
BNGO stock has been stuck in a range, but its next move should be to the upside based on Bionano's breakthrough genome mapping system.
Via
InvestorPlace
If You Invested $1,000 In BioNano Stock One Year Ago, Here's How Much You'd Have Now
September 09, 2021
Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 37.1...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Price Is Right for BioNano Genomics Given Saphyr’s Potential
August 30, 2021
With its Saphyr system seeing adoption ramp up, the long-term growth potential for BNGO stock is considerable.
Via
InvestorPlace
Bionano Stock Will Soar as the Company’s Diagnostic System Catches On
August 18, 2021
As more payors reimburse labs for using Bionano's Saphyr device, the company's financial results will improve, lifting BNGO stock.
Via
InvestorPlace
Faster and Better Clinical Outcomes Make the Case for Bionano Genomics
August 05, 2021
Bionano Genomics is mastering the science of genome mapping, while a reduced-price BNGO stock has a clear path forward for investors.
Via
InvestorPlace
Bionano Genomics, Inc (BNGO) Q2 2021 Earnings Call Transcript
August 05, 2021
BNGO earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Bionano’s Technology Is Interesting, But Its Earnings Are Uninspiring
August 02, 2021
Bionano could become a decent testing company within its niche. However, BNGO stock has run far ahead of the company's fundamentals.
Via
InvestorPlace
AMC Entertainment Tops Q2 Trends For Millenials And Gen Z, WISH Enters The Top 100
July 26, 2021
A quarterly report from Apex Clearing shows what the top owned stocks are among Millenials and Gen Z. Here is a look at the top holdings and the biggest movers from the first...
Via
Benzinga
Weak Fundamentals Prove There Is No Reason to Buy Bionano Genomics
July 23, 2021
Bionano Genomics is risky and its valuation does not justify its price. There is no compelling argument for a buy in BNGO stock.
Via
InvestorPlace
You’d Be Wrong to Paint Bionano Genomics Stock With the Meme-Stock Brush
July 16, 2021
With Bionano's disruptive tool, Saphyr, poised to revolutionize the DNA analysis sector, investors should definitely look to buy BNGO stock on its recent dip.
Via
InvestorPlace
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week
July 16, 2021
The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.
Via
The Motley Fool
Unusual Options Activity Insight: Bionano Genomics
July 09, 2021
Bionano Genomics (NASDAQ:BNGO) shares experienced unusual options activity on Friday. The stock price moved up to $6.71 following the option alert. Sentiment: BULLISH Option...
Via
Benzinga
Cramer Gives His Opinion On RadNet, Nano Dimension And More
July 07, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said RadNet Inc. (NASDAQ: RDNT) is a great situation and he likes the stock. BioNano Genomics Inc (NASDAQ: BNGO) is...
Via
Benzinga
Understanding Bionano Genomics's Unusual Options Activity
July 01, 2021
Shares of Bionano Genomics (NASDAQ:BNGO) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to $7.05. Sentiment:...
Via
Benzinga
Bionano Genomics Stock Has Short-Term Opportunities
June 28, 2021
BNGO stock has established a reliable trading range. Even long-term investors can game it while they wait for their long-term reward.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.